Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
July 2008
July 2
July 3
July 7
APP Pharmaceuticals to Be Acquired by Fresenius
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd.
Merger Consideration Established at $14.82 Per Share
Introgen Reduces Development Staff to Focus on Commercial
Activities after Advexin Regulatory Filings in U.S. and Europe
Global Pharmaceutical Industry at a Crossroads
July 8
July 9
Lilly to Acquire SGX Pharmaceuticals
New Casa Report Finds: Most Web Sites Selling Prescription Opioids,
Stimulants and Depressants Require No Prescription
Solvay Pharmaceuticals S.A. Increases to Eur 6.50 Per Share Its
Initial Tender Offer to Acquire Innogenetics
Second Quarter Health Care M&A Strongest In Years According To
New Report From Irving Levin Associates, Inc.
FDA Revises Process for Responding to Drug Applications
Wyeth's Motion to Overturn Punitive Damages Award Granted by
Arkansas Court
July 10
Novartis Buys Additional 51.7% Stake in Speedel and Announces Plans
to Acquire Remaining Shares in a Mandatory Public Tender Offer
PhRMA Revised Marketing Code Reinforces Commitment to Responsible
Interactions With Healthcare Professionals
Ratio-morphine Tablets Recalled in Canada Due to Risk of Accidental
Overdose
Insmed Announces First Human Bioequivalence Data for a Follow-on
Biologic by a U.S. Company
New Study Shows Physicians Use Numerous Sources to Inform
Prescribing Decisions for Patients
Johnson & Johnson Announces Commitment To Adopt Revised PhRMA
Marketing Code for Responsible Interactions With Healthcare
Professionals
Enlight Biosciences Launched in Collaboration with Merck & Co.,
Inc., Pfizer, and Eli Lilly
Pharmaceutical Companies Spend More in Vermont in 2007, Says
Attorney General Sorrell
Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem
Corp.
FDA MedWatch - Herceptin 440mg Vials & BWFI Diluent-Complaints
of Damaged and Broken Vials That May Lead to a Loss of Sterility
Templeton Asset Management Rejects Sun Pharmaceutical's Tender
Offer for Taro Pharmaceutical
July 11
Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug
Application with a Paragraph IV Certification for Generic Version
of Copaxone
Richard F. Selden, Former CEO of a Massachusetts Biotechnology
Company, Settles SEC Fraud Action
Statement of the Coalition for Healthcare Communication On the
Value of Independent Commercial Providers of CME
July 14
Ranbaxy Issues Statement on DOJ Investigation of Drugs Sold in U.S.
Alcon Terminates the Development of Anecortave Acetate in
Age-Related Macular Degeneration
Ortho Biotech and Amgen Resolve Antitrust Litigation
Neurogen Announces Suspension of Insomnia Study with Adipiplon
FDA Updates Label for Avandia to Include Clinical Findings
Demonstrating Sustained Glycemic Control for Up to Five Years
Actelion and GlaxoSmithKline Enter Into Exclusive Collaboration to
Realise the Full Potential of Almorexant in Sleep Disorders and
Beyond
Two New Jersey Hormone Therapy Lawsuits Dismissed
FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports
of Microangiopathic Hemolytic Anemia In Patients Treated With This
Combination
July 15
Genentech Announces Second Quarter 2008 Results
Company Suspended From ABPI Membership Over Breaches Of Code Of
Practice
Infinity Provides Update On Phase 2 Signal-Finding Clinical Study
of IPI-504 in Advanced Prostate Cancer
Jerini Receives European Commission Approval for Firazyr
(Icatibant) in the Treatment of HAE
MediGene Publishes Update on RhuDex Incident
July 16
BioAlliance Pharma Suspends the Phase II/III Trial of Doxorubicin
Transdrug in Primary Liver Cancer
Global Market for Cancer Therapies Slated for High Growth Through
2013
Bristol-Myers Squibb Agrees to Pay More Than $9 Million to
Massachusetts Medicaid Program to Settle Allegations of Improper
Marketing and Business Practices
Procter & Gamble Announces Organizational Changes
Concerned Shareholders of Biovail Pleased with Court Order for
Biovail AGM
SEC Charges Mayor of Beaufort, S.C., With Insider Trading in Stock
of Biotech Company
Concerned Shareholders Respond to Biovail's Press Release
July 17
Baxter Raises Full-Year 2008 Outlook Following Strong
Second-Quarter Financial Results
Daiichi Sankyo and Ranbaxy Confirm Deal is Binding and Final, Allay
Market Rumour and Speculation
Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
FDA Advisory Committee Provides Opinion of Doribax for the
Treatment of Hospital-Acquired Pneumonia
Novartis Gains Momentum with Strong Performance in First Half of
2008 from Portfolio Focused on Growth Areas of Healthcare
Bellus Health Announces Closing of Innodia Acquisition
New Report: Investment in Disease Prevention Could Save America
More than $16 Billion in Five Years
Statement: NIAID Will Not Move Forward with the Pave 100 HIV
Vaccine Trial VRC
July 18
July 21
Roche Makes Offer to Acquire All Outstanding Shares of Genentech
for US$89.00 Per Share in Cash
Roche Proposes to buy Full Stake in Genentech - Interview With
Chairman
Biota Holdings Limited (ASX:BTA) and GSK Conclude Litigation
Through Mediation
FDA Rule and Companion Guidance Make Early Stage Clinical Drug
Development Safe and Efficient
Roche Posts Very Good Results: Strong Market Outperformance –
Guidance Confirmed
Genentech Announces Receipt of Proposal From Roche
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of
Ezetimibe
July 22
Schering-Plough Reports Financial Results for Second Quarter of 2008
Forest Laboratories, Inc. Reports Fiscal First Quarter 2009 Earnings Per Share of $0.79, Including $0.08 per Share Charge for Agreement Termination
Roche Acquires Mirus to Advance Research in the Field of RNAi Delivery
Biogen Idec Reports Second Quarter 2008 Results
Merck Reports Second-Quarter 2008 Financial Results
July 23
Roche Starts Acquisition Process of Arius to Gain Access to New Screening Platform for Antibody Therapeutics
Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance
Pfizer Reports Second-Quarter 2008 Results
Progen Terminates Pathway Trial & Confirms Focus on Potential High Value Molecules and M&A
Dingell, Stupak to Investigate Ranbaxy Drug Approvals
GSK Sets Out New Strategic Priorities
Dan Troy Appointed as Senior Vice President and General Counsel for GlaxoSmithKline
GSK Enters Transformational Agreement with Aspen to Drive Growth in Emerging Markets
Erythropoietins: The Shift from Biosimilars to "more for less" ESAs
July 24
Alcon's Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent
Lilly Reports Solid Second-Quarter Results
Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth
Pharmacopeia Advances Therapeutic Program with GlaxoSmithKline
Cohen Milstein Hausfeld & Toll P.L.L.C. Files Lawsuit Concerning Genentech Buyout
Solvay Pharmaceuticals S.A. Plans the Offer Period for Innogenetics from August 12 to September 5, 2008
Biogenerics Would Reduce Health Care Costs for Patients, Says GPhA High Health Care Costs the Focus of Joint Economic Committee Hearing
July 25
July 29
Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14
Mylan Acquires Remaining Interest in Somerset Joint Venture From Watson
Harris Poll: Number of "Cyberchondriacs" - Adults Going Online for Health Information - Has Plateaued or Declined
Acusphere Announces Staff Reductions
Statins May Protect Against Memory Loss
Schweizerhall: Clopidogrel in Germany – Court Orders Immediate Execution of Approval
SDI Acquires Verispan
July 30
July 31
FDA Issues Complete Response Letters Ordering Safety Labeling Changes Under FDAAA for Aranesp, Epogen, and Procrit
Amgen Issues Statement in Response to Revised ESA Labeling Received from the FDA Today
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Sanofi-aventis News
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade
AstraZeneca PLC Second Quarter and Half Year Results
Photos: Bayer Names New U.S. CEO
